Replimune Group, Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Replimune Group, Inc. reported Cash And Cash Equivalents At Carrying Value of $111.12 million for the year ending 2025.

  • Replimune Group, Inc. showed an increase of +49.2% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from Replimune Group, Inc.'s annual report (Form 10-K), filed with the SEC on May 22, 2025.
  • XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 8 years of available data (2018 to 2025), Replimune Group, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 532.0%.
  • Historical annual values: Fiscal year 2025: $111.12 million | Fiscal year 2024: $74.46 million | Fiscal year 2023: $146.59 million | Fiscal year 2022: $105.95 million | Fiscal year 2021: $182.52 million | Fiscal year 2020: $59.50 million | Fiscal year 2019: $25.70 million | Fiscal year 2018: $17.58 million.
  • Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: